Prevalence and Psychosocial Impact of Coronavirus Disease 2019 in Chronic Hemodialysis Patients in Dakar, Saint-Louis, and Ziguinchor: A Prospective Multicentric Study between February 2020 and June 2020

• Published in: Saudi journal of kidney diseases and transplantation 2023-01, Vol.34 (6), p.634-641
• Main Authors: Ndongo Modou, Moustapha, Faye, Seck Sidy Mohamed, Ba Mamadou Aw, Latou, Lot Motoula, Gnagna, Faye, Ka El hadj Fary, Niang Abdou, Diouf Boucar
• Format: Article
• Language: English
• Subjects: Coronaviruses; COVID-19; Hemodialysis
• ISSN: 1319-2442; 2320-3838
• DOI: 10.4103/sjkdt.sjkdt_594_21

Chronic hemodialysis (HD) patients are particularly vulnerable to coronavirus disease 2019 (COVID-19). We assessed the prevalence and psychosocial impact of COVID-19 in these patients in Senegal. This multicenter prospective, descriptive, and analytical study included 345 patients who had been on chronic HD for at least 1 month (average age = 49.67 ± 14.58 years; sex ratio: 1.14). Eighty-one patients (23.48%) believed that COVID-19 negatively impacted their dialysis treatment. In total, 257 patients (74.49%) perceived themselves to be at risk, and 128 patients (37.1%) were worried about attending the dialysis center. Only 109 patients (31.59%) were tested by polymerase chain reaction; 13 (11.92%) were positive. In total, 322 patients (93.6%) were informed through television or radio, 338 (97.97%) were aware of the barrier measures, and 83 (24.06%) had difficulty applying the barrier measures, mainly on transport. Masks were the best-known measure, as reported by 331 patients (95.94%). In a bivariate analysis, knowledge of the barrier measures was associated with education level (P